SCHEMBL16626709

SCHEMBL16626709

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3c(Cl)cc(Cl)cc3Cl)ccc12

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
HTR6 P50406 11/20 0.38
IDE P14735 1/20 0.38
HTT P42858 1/20 0.35
TSHR P16473 1/20 0.34
CYP19A1 P11511 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618884 0.99 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626467 0.93 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16619112 0.92 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL17971531 0.92 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626691 0.91 HTT (0.38) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16618963 0.91 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626438 0.91 HTR6 (0.39) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16619096 0.91 HTT (0.38) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16618754 0.90 HTR6 (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626671 0.90 HTR6 (0.41) PDE4APDE4BPDE4CPDE4DHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
CN-105612150-A Sulfonylindole derivatives and process for producing the same DAE WOONG PHARMA 2016-05-25 CN claimed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI PDE4A 2460/4885PDE4B 1996/4885PDE4C 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.